BSE filing, NSE: STANCAP. Summary written from the filing by ALFA Finder's alert engine.
Standard Capital Markets Ltd: key numbers
- Share price
- ₹0.28
- Market cap
- ₹68.73 Cr
- Revenue (annual)
- ₹363.0 Cr
- Net profit (annual)
- ₹79.92 Cr
- P/E (TTM)
- 22.7×Sector 19.7×
- Promoter holding
- 2.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Standard Capital Markets Ltd
All →Standard Capital Markets Management Change
Standard Capital Markets shuffled leadership: Jindal becomes CEO, Krishnan MD, Gautam CCO, with a new Company Secretary. The board also withdrew its proposed ₹1,200 Cr CCPS investment in Sunbridge Solar.
- Value
- ₹1,200 Cr
Standard Capital Markets Management Change
Mr. Ram Gopal Jindal has ceased to hold the position of Managing Director of Standard Capital Markets Ltd, effective September 29, 2026. He remains an Executive Director.
Standard Capital Markets Annual General Meeting
Standard Capital Markets Limited concluded its 39th Annual General Meeting on September 29, 2026. Members approved financial statements, director re-appointments, and material related-party transactions.
Standard Capital Markets Insolvency Petition
Standard Capital Markets Ltd has received NCLT approval for its Resolution Plan for Bhagirath Construction Company Private Limited. The plan became effective on September 9, 2026.
Standard Capital Markets Annual Report
Standard Capital Markets Ltd submitted its Annual Report for the financial year 2025-26, along with the notice for its 39th Annual General Meeting.
Standard Capital Markets Annual General Meeting
Standard Capital Markets Ltd scheduled its 39th Annual General Meeting for September 29, 2026. The agenda includes shareholder approvals for related party transaction limits.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.